ISRCTN77656437已完成未知
High cut-off Continuous venovenous haemodialysis (CVVHD) to improve haemodynamic stability and Organ function scores in patients treated for acute renal failure after Systemic inflammatory response Syndrome (SIRS)/septic shock
Gambro Dialysatoren GmbH (Germany)0 个研究点目标入组 120 人开始时间: 2006年3月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Fulfilling at least two of the SIRS criteria as defined by the American College of Chest Physicians (ACCP)/Society of Critical Care Medicine (SCCM) Consensus Conference
- •2. Having signs of renal dysfunction
- •3. Requirement for catecholamine administration (norepinephrine or others)
- •4. Acute Physiology And Chronic Health Evaluation (APACHE II) score at enrolment greater than or equal to 19 and less than or equal to 30
排除标准
- •1. Lack of written informed consent from patients or a legally authorized surrogate
- •2. Duration of septic shock greater than 4 days
- •3. Hypoproteinaemia (characterized by serum albumin less than 18 g/l)
- •4. End stage renal failure
- •5. Known active malignancy
- •6. Known human immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) infection
- •7. Age younger than 18 years or older than 80 years
- •8. Known pregnancy
- •9. Immunosuppression after transplantation
- •10. Participation in another clinical study
- •11. Renal replacement therapy greater than 24 hours before randomisation
研究者
相似试验
已完成
4 期
Continuous veno-venous hemodialysis with citrate anticoagulation using a dedicated dialysatePatients 20 years of age or older for whom continuous hemodialysis is determined to be necessaryJPRN-UMIN000014911Intensive Care Unit, Department of Anesthesiology, Jikei University School of Medicine10
招募中
Unknown
Promoting haemostasis for central venous access devices: a randomised controlled trialCentral venous access device - associated bleedingCentral Venous Access Device - dressing failureCentral Venous Access Device - infectionPublic Health - Health service researchACTRN12624000366550niversity of Wollongong160
进行中（未招募）
不适用
High volume haemodiafiltration in treatment of severe sepsis -- impact on pharmacokinetics of doripenem and piperacillin tazobactam and inflammatory responseadult intensive care patient with severe sepsis or septic shock and acute renal failure requiring renal replacement therapyMedDRA version: 13.1Level: PTClassification code 10040047Term: SepsisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 13.1Level: LLTClassification code 10001041Term: Acute renal failureSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 13.1Level: PTClassification code 10053879Term: Sepsis syndromeSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-000644-16-EEniversity of Tartu, Clinic of Anaesthesiology and Intensive Care30
终止
不适用
High Cut-Off Continuous Veno-venous Hemodialysis (CVVHD) in Patients Treated for Acute Renal Failure After Systemic Inflammatory Response Syndrome (SIRS)/Septic ShockKidney Failure, AcuteSystemic Inflammatory Response SyndromeNCT00875888Vantive Health LLC80
进行中（未招募）
1 期
Evaluation of HCV clearance by hemodialysisChronic hepatitis C in patients with chronic renal failureMedDRA version: 9.1Level: LLTClassification code 10008912Term: Chronic hepatitis CMedDRA version: 9.1Level: LLTClassification code 10066622Term: Chronic hemodialysisEUCTR2008-006772-30-ATMedical University of Graz